No small surprise - Small cell carcinoma of the ovary, hypercalcaemic type, is a malignant rhabdoid tumour

Journal of Pathology

Volumn 233, Issue 3, 2014, Pages 209-214

  Foulkes, William D ^a,b,c   Clarke, Blaise A ^d   Hasselblatt, Martin ^e   Majewski, Jacek ^b   Albrecht, Steffen ^f   McCluggage, W Glenn ^g  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f MONTREAL CHILDREN S HOSPITAL   (Canada)

^g ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

hypercalcaemic type; rhabdoid tumour; small cell carcinoma of the ovary; SMARCB1

Indexed keywords

BRG1 PROTEIN; FORMALDEHYDE; PARAFFIN; DNA BINDING PROTEIN; DNA HELICASE; NONHISTONE PROTEIN; NUCLEAR PROTEIN; SMARCA4 PROTEIN, HUMAN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; CANCER MORPHOLOGY; CORRELATION ANALYSIS; EXOME; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PRIORITY JOURNAL; RARE DISEASE; RHABDOID TUMOR; SMALL CELL CARCINOMA; SMALL CELL CARCINOMA OF THE OVARY HYPERCALCEMIC TYPE; SMARCA4 GENE; SMARCB1 GENE; WHOLE EXOME SEQUENCING; CHEMISTRY; DNA SEQUENCE; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HYPERCALCAEMIC TYPE; METABOLISM; MUTATION; OVARY TUMOR; PATHOLOGY; PHENOTYPE; RHABDOID TUMOUR; SMALL CELL CARCINOMA OF THE OVARY; SMARCB1;

HYPERCALCAEMIC TYPE; RHABDOID TUMOUR; SMALL CELL CARCINOMA OF THE OVARY; SMARCB1;

CARCINOMA, SMALL CELL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA HELICASES; DNA-BINDING PROTEINS; EXOME; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; MUTATION; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PHENOTYPE; RHABDOID TUMOR; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902358492     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4362     Document Type: Article

References (51)

1. Rorke LB, Packer R, Biegel J,. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol 1995; 24 (1): 21-28.
2. Beckwith JB, Palmer NF,. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978; 41 (5): 1937-1948.
3. Brennan B, Stiller C, Bourdeaut F,. Extracranial rhabdoid tumours: what we have learned so far and future directions. Lancet Oncol 2013; 14 (8): e329-336.
4. Haas JE, Palmer NF, Weinberg AG, et al., Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 1981; 12 (7): 646-657.
5. Mayes LC, Kasselberg AG, Roloff JS, et al., Hypercalcemia associated with immunoreactive parathyroid hormone in a malignant rhabdoid tumor of the kidney (rhabdoid Wilms' tumor). Cancer 1984; 54 (5): 882-884.
6. Weeks DA, Beckwith JB, Mierau GW, et al., Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989; 13 (6): 439-458.
7. Amar AM, Tomlinson G, Green DM, et al., Clinical presentation of rhabdoid tumors of the kidney. J Pediatr Hematol Oncol 2001; 23 (2): 105-108.
8. Rorke-Adams LB,. Memoir: curiosity rewarded! J Neuropathol Exp Neurol 2013; 72 (9): 895-904.
9. Rorke LB, Packer RJ, Biegel JA,. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996; 85 (1): 56-65.
10. Biegel JA, Rorke LB, Emanuel BS,. Monosomy 22 in rhabdoid or atypical teratoid tumors of the brain. N Engl J Med 1989; 321 (13): 906.
11. Shashi V, Lovell MA, von Kap-Herr C, et al., Malignant rhabdoid tumor of the kidney: involvement of chromosome 22. Genes Chromosomes Cancer 1994; 10 (1): 49-54.
12. Versteege I, Sevenet N, Lange J, et al., Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998; 394 (6689): 203-206.
13. Biegel JA, Zhou JY, Rorke LB, et al., Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999; 59 (1): 74-79.
14. Biegel JA, Fogelgren B, Wainwright LM, et al., Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor. Genes Chromosomes Cancer 2000; 28 (1): 31-37.
15. Eaton KW, Tooke LS, Wainwright LM, et al., Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011; 56 (1): 7-15.
16. Sevenet N, Sheridan E, Amram D, et al., Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 1999; 65 (5): 1342-1348.
17. Bruggers CS, Bleyl SB, Pysher T, et al., Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 2011; 56 (7): 1026-1031.
18. Judkins AR, Mauger J, Ht A, et al., Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004; 28 (5): 644-650.
19. Fruhwald MC, Hasselblatt M, Wirth S, et al., Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 2006; 47 (3): 273-278.
20. Schneppenheim R, Fruhwald MC, Gesk S, et al., Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 2010; 86 (2): 279-284.
21. Hasselblatt M, Gesk S, Oyen F, et al., Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 2011; 35 (6): 933-935.
22. Witkowski L, Lalonde E, Zhang J, et al., Familial rhabdoid tumour 'avant la lettre'-from pathology review to exome sequencing and back again. J Pathol 2013; 231 (1): 35-43.
23. Scully RE,. Tumors of the ovary and maldeveloped gonads. In Atlas of Tumor Pathology, Series 2, Fascicle 16, Hartmann WH, Cowan WR, (eds). Armed Forces Institute of Pathology: Washington, DC, 1979; 239-312.
24. Eichhorn JH, Young RH, Scully RE,. Primary ovarian small cell carcinoma of pulmonary type. A clinicopathologic, immunohistologic, and flow cytometric analysis of 11 cases. Am J Surg Pathol 1992; 16 (10): 926-938.
25. Clement PB,. Selected miscellaneous ovarian lesions: small cell carcinomas, mesothelial lesions, mesenchymal and mixed neoplasms, and non-neoplastic lesions. Mod Pathol 2005; 18 (suppl 2): S113-129.
26. McCluggage WG,. Ovarian neoplasms composed of small round cells: a review. Adv Anat Pathol 2004; 11 (6): 288-296.
27. Rouzbahman M, Clarke B,. Neuroendocrine tumors of the gynecologic tract: select topics. Semin Diagn Pathol 2013; 30 (3): 224-233.
28. McCluggage WG, Oliva E, Connolly LE, et al., An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type. Int J Gynecol Pathol 2004; 23 (4): 330-336.
29. Young RH, Oliva E, Scully RE,. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994; 18 (11): 1102-1116.
30. Ulbright TM, Roth LM, Stehman FB, et al., Poorly differentiated (small cell) carcinoma of the ovary in young women: evidence supporting a germ cell origin. Hum Pathol 1987; 18 (2): 175-184.
31. Abeler V, Kjorstad KE, Nesland JM,. Small cell carcinoma of the ovary. A report of six cases. Int J Gynecol Pathol 1988; 7 (4): 315-329.
32. Distelmaier F, Calaminus G, Harms D, et al., Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease. Cancer 2006; 107 (9): 2298-2306.
33. Bakhru A, Liu JR, Lagstein A,. A case of small cell carcinoma of the ovary hypercalcemic variant in a teenager. Gynecol Oncol Case Rep 2012; 2 (4): 139-142.
34. Banzai C, Yahata T, Sasahara J, et al., Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature. Gynecol Oncol 2007; 105 (1): 261-265.
35. Witkowski L, Carrot-Zhang J, Albrecht S, et al., Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet 2014; 46 (5): 438-443.
36. Lee RS, Stewart C, Carter SL, et al., A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest 2012; 122 (8): 2983-2988.
37. Kupryjanczyk J, Dansonka-Mieszkowska A, Moes-Sosnowska J, et al., Ovarian small cell carcinoma of hypercalcemic type-evidence of germline origin and smarca4 gene inactivation. A pilot study. Pol J Pathol 2013; 64 (4): 238-246.
38. Jelinic P, Mueller JJ, Olvera N, et al., Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet 2014; 46 (5): 424-426.
39. Ramos P, Karnezis AN, Craig DW, et al., Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet 2014; 46 (5): 427-429.
40. Lathrop GM, Lalouel JM, Julier C, et al., Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 1984; 81 (11): 3443-3446.
41. Majewski J, Schwartzentruber J, Lalonde E, et al., What can exome sequencing do for you? J Med Genet 2011; 48 (9): 580-589.
42. Majewski J, Rosenblatt DS,. Exome and whole-genome sequencing for gene discovery: the future is now! Hum Mutat 2012; 33 (4): 591-592.
43. Comino-Mendez I, Gracia-Aznarez FJ, Schiavi F, et al., Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma. Nat Genet 2011; 43 (7): 663-667.
44. Smith MJ, O'Sullivan J, Bhaskar SS, et al., Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet 2013; 45 (3): 295-298.
45. Lawrence MS, Stojanov P, Mermel CH, et al., Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014; 505 (7484): 495-501.
46. Van Allen EM, Wagle N, Sucker A, et al., The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov 2014; 4 (1): 94-109.
47. Johnson S., The Lives of the Most Eminent English Poets, with Critical Observations on Their Works. London: 1779.
48. Grupenmacher AT, Halpern AL, Bonaldo MF, et al., Study of the gene expression and microRNA expression profiles of malignant rhabdoid tumors originated in the brain (AT/RT) and in the kidney (RTK). Childs Nerv Syst 2013; 29 (11): 1977-1983.
49. Pomeroy SL, Tamayo P, Gaasenbeek M, et al., Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002; 415 (6870): 436-442.
50. Lee RS, Roberts CW,. Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer. Brain Pathol 2013; 23 (2): 200-205.
51. Voltaire. Essai sur l'histoire générale et sur les mœurs et l'esprit des nations, Chapter 70; 1756.